362 CHAPTER 4.3 Table 2. Frequency, type, and detectability of medication errors (MEs) per adverse drug event. Adverse drug event Total MEs Underuse Overuse Misuse ME detectability n (% total) % (n) Drug (n) % (n) Drug (n) % (n) Drug (n) % MEs present during medication review (n) % present MEs detected by STOPP/ START, (n) Based on explicit trigger toola [14] Heart failure exacerbation 20 (26.0) 90.0 (18) ACE-Ib (8) Beta blockerb (3) Diureticsc (7) 5.0 (1) NSAID (1) 5.0 (1) Sotalolg (1) 45.0 (9/20) 66.7 (6/9) Fall/fracture 16 (20.8) 25.0 (4) Calcium and/or vitamin D (2) Bisphosphonates (1) Metformind (1) 68.8 (11) Antidepressants (3) Urinary antispasmodics (2) Benzodiazepines (2) Beta blockers (1) Nitrates (1) Dopamine agonist (1) PPI (1) 6.3 (1) Ciprofloxacing (1) 56.3 (9/16) 66.7 (6/9) Bleeding 8 (10.4) 0.0 (0) N/A 87.5 (7) Antiplatelet therapy (5) Anticoagulation (2) 12.5 (1) Antiplatelet therapy (1) 50.0 (5/8) 80.0 (4/5) Myocardial infarction or ischemic disease 5 (6.5) 100.0 (5) Anticoagulatione (1) ACE-I (2) Antiplatelet therapy (1) Statin (1) 0.0 (0) N/A 0.0 (0) N/A 40.0 (3/5) 66.7 (2/3) Uncontrolled pain
RkJQdWJsaXNoZXIy MTk4NDMw